欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号AT/H/0364/002
药品名称Dacepton 5 mg/ml solution for infusion
活性成分
    • apomorphine hydrochloride hemihydrate 5.0 mg/ml
剂型Solution for infusion
上市许可持有人EVER Neuro Pharma GmbH Oberburgau 3 4866 Unterach, Austria
参考成员国 - 产品名称Austria (AT)
Dacepton 5 mg/ml Infusionslösung
互认成员国 - 产品名称
    • Denmark (DK)
    • Netherlands (NL)
      Dacepton 5 mg/ml oplossing voor infusie
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
      DOPACEPTIN
    • Norway (NO)
      Dacepton
    • Poland (PL)
      Dacepton
    • Latvia (LV)
      Dacepton 5 mg/ml šķīdums infūzijām
    • Estonia (EE)
      DACEPTON 5 MG/ML
    • Hungary (HU)
      DACEPTON 5 mg/ml oldatos infúzió
    • Bulgaria (BG)
      Dacepton
    • Czechia (CZ)
      Dacepton® 5mg/ml Infuzní roztok
    • Romania (RO)
      Dacepton® 5mg/ml Soluţie perfuzabilă
    • Slovakia (SK)
    • Slovenia (SI)
    • Croatia (HR)
    • Luxembourg (LU)
    • Sweden (SE)
    • Germany (DE)
      Dacepton 5 mg/ml Injektions-/Infusionslösung
    • Belgium (BE)
      Dacepton
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Finland (FI)
      Dacepton 5 mg/ml infuusioneste, liuos
    • Lithuania (LT)
      Dacepton 5mg/ml infuzinis tirpalas
许可日期2014/01/21
最近更新日期2024/02/23
药物ATC编码
    • N04BC07 apomorphine
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase